Luma, don't be surprised if one morning there is a news that FDA is reconsidering its use. HB is relentless inthe pursuit for front line. As we speak amidst their silence, they are working for ways and means with the FDA to allow patients to get this treatment. This is how biotech operates.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.